JP2017523152A5 - - Google Patents

Download PDF

Info

Publication number
JP2017523152A5
JP2017523152A5 JP2016574454A JP2016574454A JP2017523152A5 JP 2017523152 A5 JP2017523152 A5 JP 2017523152A5 JP 2016574454 A JP2016574454 A JP 2016574454A JP 2016574454 A JP2016574454 A JP 2016574454A JP 2017523152 A5 JP2017523152 A5 JP 2017523152A5
Authority
JP
Japan
Prior art keywords
optionally substituted
pharmaceutically acceptable
acceptable salt
stereoisomer
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016574454A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017523152A (ja
JP6521535B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/037812 external-priority patent/WO2015200709A1/en
Publication of JP2017523152A publication Critical patent/JP2017523152A/ja
Publication of JP2017523152A5 publication Critical patent/JP2017523152A5/ja
Application granted granted Critical
Publication of JP6521535B2 publication Critical patent/JP6521535B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016574454A 2014-06-25 2015-06-25 ヒストンデメチラーゼ阻害剤 Active JP6521535B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462017201P 2014-06-25 2014-06-25
US62/017,201 2014-06-25
PCT/US2015/037812 WO2015200709A1 (en) 2014-06-25 2015-06-25 Histone demethylase inhibitors

Publications (3)

Publication Number Publication Date
JP2017523152A JP2017523152A (ja) 2017-08-17
JP2017523152A5 true JP2017523152A5 (en22) 2018-08-09
JP6521535B2 JP6521535B2 (ja) 2019-05-29

Family

ID=54929774

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016574454A Active JP6521535B2 (ja) 2014-06-25 2015-06-25 ヒストンデメチラーゼ阻害剤

Country Status (29)

Country Link
US (7) US10385047B2 (en22)
EP (3) EP3160952B1 (en22)
JP (1) JP6521535B2 (en22)
KR (1) KR102591897B1 (en22)
CN (2) CN111909083B (en22)
AR (1) AR100997A1 (en22)
AU (1) AU2015279719B2 (en22)
BR (1) BR112016030367A2 (en22)
CA (1) CA2953437C (en22)
CL (1) CL2016003301A1 (en22)
CO (1) CO2017000359A2 (en22)
CY (1) CY1123906T1 (en22)
DK (1) DK3160952T3 (en22)
EA (1) EA031200B1 (en22)
EC (1) ECSP17004931A (en22)
ES (1) ES2862648T3 (en22)
HR (1) HRP20210299T1 (en22)
HU (1) HUE053876T2 (en22)
IL (1) IL249629A0 (en22)
LT (1) LT3160952T (en22)
MX (1) MX375219B (en22)
NZ (1) NZ728120A (en22)
PL (1) PL3160952T3 (en22)
PT (1) PT3160952T (en22)
SA (1) SA516380585B1 (en22)
SG (1) SG11201610813TA (en22)
SI (1) SI3160952T1 (en22)
TW (2) TWI715533B (en22)
WO (1) WO2015200709A1 (en22)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2718495T3 (es) 2012-12-21 2019-07-02 Celgene Quanticel Res Inc Inhibidores de la histona desmetilasa
NZ728120A (en) 2014-06-25 2023-06-30 Celgene Quanticel Res Inc Histone demethylase inhibitors
US9643965B2 (en) 2014-09-17 2017-05-09 Celgene Quantical Research, Inc. Histone demethylase inhibitors
US10030017B2 (en) 2014-09-17 2018-07-24 Celgene Quanticel Research, Inc. Histone demethylase inhibitors
WO2017117154A1 (en) * 2015-12-28 2017-07-06 Celgene Quanticel Research, Inc. Histone demethylase inhibitors
JP6970681B2 (ja) * 2016-03-15 2021-11-24 セルジーン クオンティセル リサーチ,インク. ヒストンデメチラーゼ阻害剤
US10150754B2 (en) 2016-04-19 2018-12-11 Celgene Quanticel Research, Inc. Histone demethylase inhibitors
JP7442439B2 (ja) * 2017-03-30 2024-03-04 アルベルト-ルートヴィヒ-ユニバーシティー フライブルク Kdm4阻害剤
CN109825551B (zh) * 2019-02-21 2022-08-02 深圳大学 一种评价组蛋白赖氨酸去甲基转移酶活性的方法
CN111679072B (zh) * 2020-06-15 2022-04-29 温州医科大学 Kdm6b蛋白在乳腺癌预后评估试剂盒、诊断试剂盒中的应用
WO2022217100A1 (en) * 2021-04-09 2022-10-13 Tachyon Therapeutics, Inc. Treatment of cancer with kdm4 inhibitors
JP2024531115A (ja) * 2021-08-18 2024-08-29 セルジーン コーポレーション ヒストン脱メチル化阻害剤を調製するためのプロセス
CA3242035A1 (en) * 2021-12-23 2023-06-29 Gowri Sukumar Pharmaceutical formulations comprising 3-({[(4r)-7-{methyl[4-(propan-2-yl)phenyl]amino}-3,4-dihydro-2h-l-benzopyran-4-yl]methyl}amino)pyridine-4-carboxylic acid
WO2023240253A2 (en) 2022-06-10 2023-12-14 Forward Therapeutics, Inc. Modulators of tnf-alpha activity
WO2023250480A1 (en) * 2022-06-23 2023-12-28 The Cleveland Clinic Foundation 3-βHSD1 INHIBITORS AND COMPOSITIONS AND USES THEREOF
KR20250067936A (ko) * 2022-09-21 2025-05-15 셀진 코포레이션 3-({[(4r)-7-{메틸[4-(프로판-2-일)페닐]아미노}-3,4-디하이드로-2h-1-벤조피란-4-일]메틸}아미노)피리딘-4-카르복실산l-라이신 염의 결정형, 히스톤 탈메틸화효소 억제제
CN115974647B (zh) * 2022-12-05 2024-09-03 江苏宏邦化工科技有限公司 以四氢-4-甲基-2-苯基-2h-吡喃-4-醇为原料制备苯乐戊醇的方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1429765A2 (en) 2001-09-14 2004-06-23 Methylgene, Inc. Inhibitors of histone deacetylase
UA89035C2 (ru) 2003-12-03 2009-12-25 Лео Фарма А/С Эфиры гидроксамовых кислот и их фармацевтическое применение
DE102004039876A1 (de) 2004-06-23 2006-01-26 Lanxess Deutschland Gmbh Herstellung von fluorierten 1,3-Benzodioxanen
TW200808793A (en) 2006-03-07 2008-02-16 Smithkline Beecham Corp Prolyl hydroxylase inhibitors
US8598168B2 (en) * 2006-04-07 2013-12-03 Methylgene Inc. Inhibitors of histone deacetylase
US7898712B2 (en) 2008-06-27 2011-03-01 Lockheed Martin Corporation Risley integrated steering module
GB201112607D0 (en) * 2011-07-22 2011-09-07 Glaxo Group Ltd Novel compounds
CA2834548C (en) * 2011-04-28 2021-06-01 The Broad Institute, Inc. Inhibitors of histone deacetylase
WO2013143597A1 (en) 2012-03-29 2013-10-03 Glaxo Group Limited Demethylase enzymes inhibitors
US20140162266A1 (en) 2012-12-05 2014-06-12 Bio-Rad Laboratories, Inc. Methods for polymerase chain reaction copy number variation assays
EP2928471B1 (en) * 2012-12-06 2020-10-14 Celgene Quanticel Research, Inc. Histone demethylase inhibitors
AU2013361255B2 (en) * 2012-12-19 2017-01-05 Celgene Quanticel Research, Inc. Histone demethylase inhibitors
ES2718495T3 (es) * 2012-12-21 2019-07-02 Celgene Quanticel Res Inc Inhibidores de la histona desmetilasa
NZ728120A (en) 2014-06-25 2023-06-30 Celgene Quanticel Res Inc Histone demethylase inhibitors
JP7442439B2 (ja) * 2017-03-30 2024-03-04 アルベルト-ルートヴィヒ-ユニバーシティー フライブルク Kdm4阻害剤

Similar Documents

Publication Publication Date Title
JP2017523152A5 (en22)
EA201992126A1 (ru) Ингибиторы jak, содержащие 4-членный гетероциклический амид
JP2017519781A5 (en22)
RU2019131111A (ru) ПРОИЗВОДНОЕ ГЕТЕРОАРИЛ[4,3-с]ПИРИМИДИН-5-АМИНА, СПОСОБ ЕГО ПОЛУЧЕНИЯ И ЕГО МЕДИЦИНСКИЕ ПРИМЕНЕНИЯ
JP2017527561A5 (en22)
JP2017514830A5 (en22)
WO2015132799A3 (en) Heterocyclic compounds
CY1120248T1 (el) Ενωσεις ιμιδαζο[4,5-c]κινολιν-2-ονης και η χρηση τους στη θεραπευτικη αντιμετωπιση του καρκινου
JP2016516699A5 (en22)
CY1119727T1 (el) Ενωσεις και συνθεσεις για τη θεραπεια παρασιτικων νοσων
JP2018519343A5 (en22)
EA201700077A1 (ru) Соединения аминопиримидинила в качестве ингибиторов jak
JP2016514159A5 (en22)
CY1118572T1 (el) Παραγωγο κυκλοαλκανιου
JP2016513137A5 (en22)
RU2017105781A (ru) Индазольные соединения в качестве ингибиторов киназы fgfr, их получение и применение
HK1243930A1 (zh) 作爲fxr/tgr5激動劑的膽汁酸類似物和其使用方法
JP2016540742A5 (en22)
JP2020502092A5 (en22)
EA201650029A1 (ru) Пиразолопиридины и пиразолопиримидины
EA201491672A1 (ru) Гетероциклильные соединения как ингибиторы mek
MX2020002924A (es) Lactamas fusionadas de arilo y heteroarilo.
EA201691136A1 (ru) Производное на основе 1,2-нафтохинона и способ его получения
WO2014031438A3 (en) SUBSTITUTED PHENYL SPLEEN TYROSINE KINASE (Syk) INHIBITORS
JP2012513416A5 (en22)